The blue coma: The role of methylene blue in unexplained coma after cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 30, Issue 2, 2016, Pages 423-427

  Martino, Enrico Antonio ^a   Winterton, Dario ^a   Nardelli, Pasquale ^a   Pasin, Laura ^a   Calabrò, Maria Grazia ^a   Bove, Tiziana ^a   Fanelli, Giovanna ^a   Zangrillo, Alberto ^a,b   Landoni, Giovanni ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Anesthesia; Coma; Intensive care; Methylene blue; Selective serotonin reuptake inhibitors; Serotonin syndrome; Thoracic surgery; Vasoplegic syndrome

Indexed keywords

ADRENALIN; ANTIPYRETIC AGENT; BENZODIAZEPINE DERIVATIVE; FENTANYL; METHYLENE BLUE; NORADRENALIN; PARACETAMOL; PROPOFOL; SEROTONIN UPTAKE INHIBITOR;

AGED; AROUSAL; ARTICLE; CASE REPORT; COMA; DIAGNOSTIC TEST; DRUG MEGADOSE; FEMALE; FORWARD HEART FAILURE; GENERAL ANESTHESIA; HEART SURGERY; HOSPITAL DISCHARGE; HUMAN; HYPERTHERMIA; INTENSIVE CARE UNIT; OBSERVATIONAL STUDY; OXYGEN THERAPY; PRIORITY JOURNAL; SEPSIS; SEROTONIN SYNDROME; TEACHING HOSPITAL; TOXICITY; VASOPLEGIA; VERY ELDERLY; ELECTROENCEPHALOGRAPHY; POSTOPERATIVE COMPLICATION;

AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; COMA; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; METHYLENE BLUE; POSTOPERATIVE COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS;

EID: 84950267614     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2015.09.011     Document Type: Article

References (30)

1. E.W. Boyer, and M. Shannon The serotonin syndrome N Engl J Med 352 2005 1112 1120
2. R.A. Ener, S.B. Meglathery, W.A. Van Decker, and et al. Serotonin syndrome and other serotonergic disorders Pain Med 4 2003 63 74
3. R.R. Ramsay, C. Dunford, and P.K. Gillman Methylene blue and serotonin toxicity: Inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction Br J Pharmacol 152 2007 946 951
4. W. Otte, T.K. Birkenhager, and W.W. Van den Broek Fatal interaction between tranylcypromine and imipramine Eur Psychiatry 18 2003 264 265
5. S. Cassens, E.A. Nickel, M. Quintel, and et al. The serotonin syndrome. Fatal course of intoxication with citalopram and moclobemide Anaesthesist 55 2006 1189 1196
6. A.M. Zonneveld, M. Hagenaars, N.C. Voermans, and et al. Life-threatening serotonin syndrome following a single dose of a serotonin reuptake inhibitor during maintenance therapy with a monoamine oxidase inhibitor Ned Tijdschr Geneeskd 150 2006 1081 1084
7. L.A. Pratt, D.J. Brody, and Q. Gu Antidepressant use in persons aged 12 and over: United States, 2005-2008 NCHS Data Brief 127 2011 1 8
8. R. Gusmão, S. Quintão, D. McDaid, and et al. Antidepressant utilization and suicide in Europe: An ecological multi-national study PLoS One 8 2013 e66455
9. L. Brunton, B. Chabner, and B. Knollman Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th ed 2011 McGraw-Hill Professional New York
10. P.K. Gillman CNS toxicity involving methylene blue: The exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity J Psychopharmacol 25 2011 429 436
11. L. Pasin, M. Umbrello, T. Greco, and et al. Methylene blue as a vasopressor: A meta-analysis of randomised trials Crit Care Resusc 15 2013 42 48
12. M.M. Weiner, H.M. Lin, D. Danforth, and et al. Methylene blue is associated with poor outcomes in vasoplegic shock J. Cardiothorac Vasc Anesth 27 2013 1233 1238
13. E.J.C. Dunkley, G.K. Isbister, D. Sibbritt, and et al. The hunter serotonin toxicity criteria: Simple and accurate diagnostic decision rules for serotonin toxicity QJM 96 2003 635 642
14. K.C. Millis Serotonin syndrome: A clinical update Crit Care Clin 13 1997 763 783
15. C. Peter, D. Hongwan, A. Küpfer, and et al. Pharmacokinetics and organ distribution of intravenous and oral methylene blue Eur J Clin Pharmacol 56 2000 247 250
16. A. Petzer, B.H. Harvey, G. Wegener, and et al. Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase Toxicol Appl Pharmacol 258 2012 403 409
17. B.K.W. Ng, and A.J.D. Cameron The role of methylene blue in serotonin syndrome: A systematic review Psychosomatics 51 2010 194 200
18. G. Shanmugam, B. Kent, T. Alsaiwadi, and et al. Serotonin syndrome following cardiac surgery Interact Cardiovasc Thorac Surg 7 2008 656 657
19. E.R. Hanna, and J.A. Clark Serotonin syndrome after cardiopulmonary bypass Anesth Analg Case Rep 2 2014 113 114
20. K.J. Grubb, J.L.W. Kennedy, J.D. Bergin, and et al. The role of methylene blue in serotonin syndrome following cardiac transplantation: A case report and review of the literature J Thorac Cardiovasc Surg 144 2012 e113 116
21. C.J. Smith, D. Wang, A. Sgambelluri, and et al. Serotonin syndrome following methylene blue administration during cardiothoracic surgery J Pharm Pract 28 2015 207 211
22. I.M. Whyte, A.H. Dawson, and N.A. Buckley Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants QJM 96 2003 369 374
23. P.K. Gillman Monoamino oxidase inhibitors, opioid analgesics and serotonin toxicity Br J Anaesth 95 2005 434 441
24. S. Ferrand Fentanyl and serotonin syndrome Can Advers React Newsl 2 2012 2 3
25. S. Pedavally, J.E. Fugate, and A.A. Rabinstein Serotonin syndrome in the intensive care unit: clinical presentations and precipitating medications Neurocrit Care 21 2014 108 113
26. R. Kirschner, and J.W. Donovan Serotonin syndrome precipitated by fentanyl during procedural sedation J Emerg Med 38 2010 477 480
27. Food and Drug Administration. FDA drug safety communication: serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm263190.htm. Accessed September 29, 2015
28. G. Landoni, L. Pasin, A.L. Di Prima, and et al. Methylene blue: between scylla (meta-analysis) and charybdis (propensity) J Cardiothorac Vasc Anesth 28 2014 e12 13
29. M.M. Weiner, and G.W. Fischer Methylene blue: the Trojan horse J Cardiothorac Vasc Anesth 28 2014 e13 14
30. A.C. Breuer, A.J. Furlan, M.R. Hanson, and et al. Central nervous system complications of coronary artery bypass graft surgery: prospective analysis of 421 patients Stroke 14 1983 682 687.